Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000200406-25-000013
Filing Date
2025-02-11
Accepted
2025-02-11 19:41:17
Documents
1
Period of Report
2025-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739320870.html 4  
1 FORM 4 wk-form4_1739320870.xml 4 6908
  Complete submission text file 0000200406-25-000013.txt   8357
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Taubert Jennifer L (Reporting) CIK: 0001745938 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-03215 | Film No.: 25611477